ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Renal Diseases Drug Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-10U6080
Home | Market Reports | Health| Health Conditions
Global Renal Diseases Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Renal Diseases Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-10U6080
Report
December 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Amgen Inc
Roche
GlaxoSmithKline(GSK )
Allergan plc
AbbVie
Kissei Pharmaceutical
Astrazeneca plc
FibroGen Inc
Sanofi
Teva Pharmaceutical Industries
Johnson & Johnson
Keryx Biopharmaceuticals

Renal Diseases Drug Market

Kidney disease commonly referred to as kidney disease or kidney disease, mainly manifested as abnormal urine volume, urination abnormalities, lumbago.Kidney disease drugs include blood pressure drugs, anti-hyperlipidemia drugs, erythropoietics (ESA), diuretics and so on.
Market Analysis and Insights: Global Renal Diseases Drug Market
The global Renal Diseases Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Renal Diseases Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Renal Diseases Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Renal Diseases Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Renal Diseases Drug include Pfizer, Amgen, Roche, GlaxoSmithKline (GSK), Allergan, AbbVie, Kissei Pharmaceutical, AstraZeneca and FibroGen, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Renal Diseases Drug is widely used in various fields, such as Hospitals, Specialty Clinics and Other,, etc. Hospitals provides greatest supports to the Renal Diseases Drug industry development. In 2023, global % revenue of Renal Diseases Drug went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Renal Diseases Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Renal Diseases Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Renal Diseases Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Renal Diseases Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Renal Diseases Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Renal Diseases Drug revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Renal Diseases Drug Market Report

Report Metric Details
Report Name Renal Diseases Drug Market
Segment by Type
  • Chronic Kidney Disease (CKD) Drugs
  • End-Stage Kidney Disease (ESRD) Drugs
Segment by Application
  • Hospitals
  • Specialty Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Amgen, Roche, GlaxoSmithKline (GSK), Allergan, AbbVie, Kissei Pharmaceutical, AstraZeneca, FibroGen, Sanofi, Teva Pharmaceutical Industries, Johnson & Johnson, Keryx Biopharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Renal Diseases Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Renal Diseases Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Renal Diseases Drug revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Renal Diseases Drug Market report?

Ans: The main players in the Renal Diseases Drug Market are Pfizer, Amgen, Roche, GlaxoSmithKline (GSK), Allergan, AbbVie, Kissei Pharmaceutical, AstraZeneca, FibroGen, Sanofi, Teva Pharmaceutical Industries, Johnson & Johnson, Keryx Biopharmaceuticals

What are the Application segmentation covered in the Renal Diseases Drug Market report?

Ans: The Applications covered in the Renal Diseases Drug Market report are Hospitals, Specialty Clinics, Other

What are the Type segmentation covered in the Renal Diseases Drug Market report?

Ans: The Types covered in the Renal Diseases Drug Market report are Chronic Kidney Disease (CKD) Drugs, End-Stage Kidney Disease (ESRD) Drugs

Recommended Reports

Renal Disease Drugs

Renal Therapy Devices

Kidney Cancer & Urology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Diseases Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chronic Kidney Disease (CKD) Drugs
1.2.3 End-Stage Kidney Disease (ESRD) Drugs
1.3 Market by Application
1.3.1 Global Renal Diseases Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Diseases Drug Market Perspective (2019-2030)
2.2 Global Renal Diseases Drug Growth Trends by Region
2.2.1 Renal Diseases Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Renal Diseases Drug Historic Market Size by Region (2019-2024)
2.2.3 Renal Diseases Drug Forecasted Market Size by Region (2025-2030)
2.3 Renal Diseases Drug Market Dynamics
2.3.1 Renal Diseases Drug Industry Trends
2.3.2 Renal Diseases Drug Market Drivers
2.3.3 Renal Diseases Drug Market Challenges
2.3.4 Renal Diseases Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Renal Diseases Drug by Players
3.1.1 Global Renal Diseases Drug Revenue by Players (2019-2024)
3.1.2 Global Renal Diseases Drug Revenue Market Share by Players (2019-2024)
3.2 Global Renal Diseases Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Renal Diseases Drug, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Renal Diseases Drug Market Concentration Ratio
3.4.1 Global Renal Diseases Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Diseases Drug Revenue in 2023
3.5 Global Key Players of Renal Diseases Drug Head office and Area Served
3.6 Global Key Players of Renal Diseases Drug, Product and Application
3.7 Global Key Players of Renal Diseases Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Diseases Drug Breakdown Data by Type
4.1 Global Renal Diseases Drug Historic Market Size by Type (2019-2024)
4.2 Global Renal Diseases Drug Forecasted Market Size by Type (2025-2030)
5 Renal Diseases Drug Breakdown Data by Application
5.1 Global Renal Diseases Drug Historic Market Size by Application (2019-2024)
5.2 Global Renal Diseases Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Renal Diseases Drug Market Size (2019-2030)
6.2 North America Renal Diseases Drug Market Size by Type
6.2.1 North America Renal Diseases Drug Market Size by Type (2019-2024)
6.2.2 North America Renal Diseases Drug Market Size by Type (2025-2030)
6.2.3 North America Renal Diseases Drug Market Share by Type (2019-2030)
6.3 North America Renal Diseases Drug Market Size by Application
6.3.1 North America Renal Diseases Drug Market Size by Application (2019-2024)
6.3.2 North America Renal Diseases Drug Market Size by Application (2025-2030)
6.3.3 North America Renal Diseases Drug Market Share by Application (2019-2030)
6.4 North America Renal Diseases Drug Market Size by Country
6.4.1 North America Renal Diseases Drug Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Renal Diseases Drug Market Size by Country (2019-2024)
6.4.3 North America Renal Diseases Drug Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Renal Diseases Drug Market Size (2019-2030)
7.2 Europe Renal Diseases Drug Market Size by Type
7.2.1 Europe Renal Diseases Drug Market Size by Type (2019-2024)
7.2.2 Europe Renal Diseases Drug Market Size by Type (2025-2030)
7.2.3 Europe Renal Diseases Drug Market Share by Type (2019-2030)
7.3 Europe Renal Diseases Drug Market Size by Application
7.3.1 Europe Renal Diseases Drug Market Size by Application (2019-2024)
7.3.2 Europe Renal Diseases Drug Market Size by Application (2025-2030)
7.3.3 Europe Renal Diseases Drug Market Share by Application (2019-2030)
7.4 Europe Renal Diseases Drug Market Size by Country
7.4.1 Europe Renal Diseases Drug Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Renal Diseases Drug Market Size by Country (2019-2024)
7.4.3 Europe Renal Diseases Drug Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Renal Diseases Drug Market Size (2019-2030)
8.2 China Renal Diseases Drug Market Size by Type
8.2.1 China Renal Diseases Drug Market Size by Type (2019-2024)
8.2.2 China Renal Diseases Drug Market Size by Type (2025-2030)
8.2.3 China Renal Diseases Drug Market Share by Type (2019-2030)
8.3 China Renal Diseases Drug Market Size by Application
8.3.1 China Renal Diseases Drug Market Size by Application (2019-2024)
8.3.2 China Renal Diseases Drug Market Size by Application (2025-2030)
8.3.3 China Renal Diseases Drug Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Renal Diseases Drug Market Size (2019-2030)
9.2 Asia Renal Diseases Drug Market Size by Type
9.2.1 Asia Renal Diseases Drug Market Size by Type (2019-2024)
9.2.2 Asia Renal Diseases Drug Market Size by Type (2025-2030)
9.2.3 Asia Renal Diseases Drug Market Share by Type (2019-2030)
9.3 Asia Renal Diseases Drug Market Size by Application
9.3.1 Asia Renal Diseases Drug Market Size by Application (2019-2024)
9.3.2 Asia Renal Diseases Drug Market Size by Application (2025-2030)
9.3.3 Asia Renal Diseases Drug Market Share by Application (2019-2030)
9.4 Asia Renal Diseases Drug Market Size by Region
9.4.1 Asia Renal Diseases Drug Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Renal Diseases Drug Market Size by Region (2019-2024)
9.4.3 Asia Renal Diseases Drug Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Renal Diseases Drug Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Renal Diseases Drug Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Renal Diseases Drug Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Renal Diseases Drug Introduction
11.1.4 Pfizer Revenue in Renal Diseases Drug Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Renal Diseases Drug Introduction
11.2.4 Amgen Revenue in Renal Diseases Drug Business (2019-2024)
11.2.5 Amgen Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Renal Diseases Drug Introduction
11.3.4 Roche Revenue in Renal Diseases Drug Business (2019-2024)
11.3.5 Roche Recent Developments
11.4 GlaxoSmithKline (GSK)
11.4.1 GlaxoSmithKline (GSK) Company Details
11.4.2 GlaxoSmithKline (GSK) Business Overview
11.4.3 GlaxoSmithKline (GSK) Renal Diseases Drug Introduction
11.4.4 GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2019-2024)
11.4.5 GlaxoSmithKline (GSK) Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Renal Diseases Drug Introduction
11.5.4 Allergan Revenue in Renal Diseases Drug Business (2019-2024)
11.5.5 Allergan Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Renal Diseases Drug Introduction
11.6.4 AbbVie Revenue in Renal Diseases Drug Business (2019-2024)
11.6.5 AbbVie Recent Developments
11.7 Kissei Pharmaceutical
11.7.1 Kissei Pharmaceutical Company Details
11.7.2 Kissei Pharmaceutical Business Overview
11.7.3 Kissei Pharmaceutical Renal Diseases Drug Introduction
11.7.4 Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2019-2024)
11.7.5 Kissei Pharmaceutical Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Renal Diseases Drug Introduction
11.8.4 AstraZeneca Revenue in Renal Diseases Drug Business (2019-2024)
11.8.5 AstraZeneca Recent Developments
11.9 FibroGen
11.9.1 FibroGen Company Details
11.9.2 FibroGen Business Overview
11.9.3 FibroGen Renal Diseases Drug Introduction
11.9.4 FibroGen Revenue in Renal Diseases Drug Business (2019-2024)
11.9.5 FibroGen Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Renal Diseases Drug Introduction
11.10.4 Sanofi Revenue in Renal Diseases Drug Business (2019-2024)
11.10.5 Sanofi Recent Developments
11.11 Teva Pharmaceutical Industries
11.11.1 Teva Pharmaceutical Industries Company Details
11.11.2 Teva Pharmaceutical Industries Business Overview
11.11.3 Teva Pharmaceutical Industries Renal Diseases Drug Introduction
11.11.4 Teva Pharmaceutical Industries Revenue in Renal Diseases Drug Business (2019-2024)
11.11.5 Teva Pharmaceutical Industries Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Renal Diseases Drug Introduction
11.12.4 Johnson & Johnson Revenue in Renal Diseases Drug Business (2019-2024)
11.12.5 Johnson & Johnson Recent Developments
11.13 Keryx Biopharmaceuticals
11.13.1 Keryx Biopharmaceuticals Company Details
11.13.2 Keryx Biopharmaceuticals Business Overview
11.13.3 Keryx Biopharmaceuticals Renal Diseases Drug Introduction
11.13.4 Keryx Biopharmaceuticals Revenue in Renal Diseases Drug Business (2019-2024)
11.13.5 Keryx Biopharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Pfizer Inc
Amgen Inc
Roche
GlaxoSmithKline(GSK )
Allergan plc
AbbVie
Kissei Pharmaceutical
Astrazeneca plc
FibroGen Inc
Sanofi
Teva Pharmaceutical Industries
Johnson & Johnson
Keryx Biopharmaceuticals
List of Tables
    Table 1. Global Renal Diseases Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chronic Kidney Disease (CKD) Drugs
    Table 3. Key Players of End-Stage Kidney Disease (ESRD) Drugs
    Table 4. Global Renal Diseases Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Renal Diseases Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Renal Diseases Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Renal Diseases Drug Market Share by Region (2019-2024)
    Table 8. Global Renal Diseases Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Renal Diseases Drug Market Share by Region (2025-2030)
    Table 10. Renal Diseases Drug Market Trends
    Table 11. Renal Diseases Drug Market Drivers
    Table 12. Renal Diseases Drug Market Challenges
    Table 13. Renal Diseases Drug Market Restraints
    Table 14. Global Renal Diseases Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Renal Diseases Drug Revenue Share by Players (2019-2024)
    Table 16. Global Top Renal Diseases Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Diseases Drug as of 2023)
    Table 17. Global Renal Diseases Drug Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Renal Diseases Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Renal Diseases Drug, Headquarters and Area Served
    Table 20. Global Key Players of Renal Diseases Drug, Product and Application
    Table 21. Global Key Players of Renal Diseases Drug, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Renal Diseases Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Renal Diseases Drug Revenue Market Share by Type (2019-2024)
    Table 25. Global Renal Diseases Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Renal Diseases Drug Revenue Market Share by Type (2025-2030)
    Table 27. Global Renal Diseases Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Renal Diseases Drug Revenue Share by Application (2019-2024)
    Table 29. Global Renal Diseases Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Renal Diseases Drug Revenue Share by Application (2025-2030)
    Table 31. North America Renal Diseases Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Renal Diseases Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Renal Diseases Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Renal Diseases Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Renal Diseases Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Renal Diseases Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Renal Diseases Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Renal Diseases Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Renal Diseases Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Renal Diseases Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Renal Diseases Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Renal Diseases Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Renal Diseases Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Renal Diseases Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Renal Diseases Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Renal Diseases Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Renal Diseases Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Renal Diseases Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Renal Diseases Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Renal Diseases Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Renal Diseases Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Renal Diseases Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Renal Diseases Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Renal Diseases Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Renal Diseases Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Renal Diseases Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Renal Diseases Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Pfizer Company Details
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Renal Diseases Drug Product
    Table 66. Pfizer Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 67. Pfizer Recent Developments
    Table 68. Amgen Company Details
    Table 69. Amgen Business Overview
    Table 70. Amgen Renal Diseases Drug Product
    Table 71. Amgen Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 72. Amgen Recent Developments
    Table 73. Roche Company Details
    Table 74. Roche Business Overview
    Table 75. Roche Renal Diseases Drug Product
    Table 76. Roche Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 77. Roche Recent Developments
    Table 78. GlaxoSmithKline (GSK) Company Details
    Table 79. GlaxoSmithKline (GSK) Business Overview
    Table 80. GlaxoSmithKline (GSK) Renal Diseases Drug Product
    Table 81. GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 82. GlaxoSmithKline (GSK) Recent Developments
    Table 83. Allergan Company Details
    Table 84. Allergan Business Overview
    Table 85. Allergan Renal Diseases Drug Product
    Table 86. Allergan Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 87. Allergan Recent Developments
    Table 88. AbbVie Company Details
    Table 89. AbbVie Business Overview
    Table 90. AbbVie Renal Diseases Drug Product
    Table 91. AbbVie Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 92. AbbVie Recent Developments
    Table 93. Kissei Pharmaceutical Company Details
    Table 94. Kissei Pharmaceutical Business Overview
    Table 95. Kissei Pharmaceutical Renal Diseases Drug Product
    Table 96. Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 97. Kissei Pharmaceutical Recent Developments
    Table 98. AstraZeneca Company Details
    Table 99. AstraZeneca Business Overview
    Table 100. AstraZeneca Renal Diseases Drug Product
    Table 101. AstraZeneca Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 102. AstraZeneca Recent Developments
    Table 103. FibroGen Company Details
    Table 104. FibroGen Business Overview
    Table 105. FibroGen Renal Diseases Drug Product
    Table 106. FibroGen Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 107. FibroGen Recent Developments
    Table 108. Sanofi Company Details
    Table 109. Sanofi Business Overview
    Table 110. Sanofi Renal Diseases Drug Product
    Table 111. Sanofi Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 112. Sanofi Recent Developments
    Table 113. Teva Pharmaceutical Industries Company Details
    Table 114. Teva Pharmaceutical Industries Business Overview
    Table 115. Teva Pharmaceutical Industries Renal Diseases Drug Product
    Table 116. Teva Pharmaceutical Industries Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 117. Teva Pharmaceutical Industries Recent Developments
    Table 118. Johnson & Johnson Company Details
    Table 119. Johnson & Johnson Business Overview
    Table 120. Johnson & Johnson Renal Diseases Drug Product
    Table 121. Johnson & Johnson Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 122. Johnson & Johnson Recent Developments
    Table 123. Keryx Biopharmaceuticals Company Details
    Table 124. Keryx Biopharmaceuticals Business Overview
    Table 125. Keryx Biopharmaceuticals Renal Diseases Drug Product
    Table 126. Keryx Biopharmaceuticals Revenue in Renal Diseases Drug Business (2019-2024) & (US$ Million)
    Table 127. Keryx Biopharmaceuticals Recent Developments
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Renal Diseases Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Renal Diseases Drug Market Share by Type: 2023 VS 2030
    Figure 3. Chronic Kidney Disease (CKD) Drugs Features
    Figure 4. End-Stage Kidney Disease (ESRD) Drugs Features
    Figure 5. Global Renal Diseases Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Renal Diseases Drug Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Specialty Clinics Case Studies
    Figure 9. Other Case Studies
    Figure 10. Renal Diseases Drug Report Years Considered
    Figure 11. Global Renal Diseases Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Renal Diseases Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Renal Diseases Drug Market Share by Region: 2023 VS 2030
    Figure 14. Global Renal Diseases Drug Market Share by Players in 2023
    Figure 15. Global Top Renal Diseases Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Diseases Drug as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Renal Diseases Drug Revenue in 2023
    Figure 17. North America Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Renal Diseases Drug Market Share by Type (2019-2030)
    Figure 19. North America Renal Diseases Drug Market Share by Application (2019-2030)
    Figure 20. North America Renal Diseases Drug Market Share by Country (2019-2030)
    Figure 21. United States Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Renal Diseases Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Renal Diseases Drug Market Share by Type (2019-2030)
    Figure 25. Europe Renal Diseases Drug Market Share by Application (2019-2030)
    Figure 26. Europe Renal Diseases Drug Market Share by Country (2019-2030)
    Figure 27. Germany Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Renal Diseases Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Renal Diseases Drug Market Share by Type (2019-2030)
    Figure 35. China Renal Diseases Drug Market Share by Application (2019-2030)
    Figure 36. Asia Renal Diseases Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Renal Diseases Drug Market Share by Type (2019-2030)
    Figure 38. Asia Renal Diseases Drug Market Share by Application (2019-2030)
    Figure 39. Asia Renal Diseases Drug Market Share by Region (2019-2030)
    Figure 40. Japan Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Renal Diseases Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Renal Diseases Drug Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Renal Diseases Drug Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Renal Diseases Drug Market Share by Country (2019-2030)
    Figure 50. Brazil Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Renal Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 57. Amgen Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 58. Roche Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 59. GlaxoSmithKline (GSK) Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 60. Allergan Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 61. AbbVie Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 62. Kissei Pharmaceutical Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 63. AstraZeneca Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 64. FibroGen Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 65. Sanofi Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 67. Johnson & Johnson Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 68. Keryx Biopharmaceuticals Revenue Growth Rate in Renal Diseases Drug Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Therapeutic Market Research Report 2025
Global Kidney Medicine Market Insights Forecast to 2030
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Medication Market Research Report 2024
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global End Stage Renal Disease Market Research Report 2024
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Global End Stage Kidney Disease Market Research Report 2024
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemodialysis Drug Market Research Report 2024
Global Dialysis Drug Market Research Report 2024
Nephrology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Renal Fibrosis Treatment Market Insights Forecast to 2030
Global End stage Renal Disease Therapeutics Market Research Report 2024
Global Kidney Cancer and Renal Cell Carcinoma RCC Drugs Market Insights Forecast to 2030
Global Chronic Kidney Disease Treatment Market Research Report 2025
Global Chronic Kidney Disease CKD Treatment Market Research Report 2025

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions